FDA Establishes New Advisory Committee on Digital Health Technologies
On October 11, 2023, the Food and Drug Administration (FDA) announced the formation of the Digital Health Advisory Committee to aid the agency in regulating the development and use of digital health technologies (DHTs), including artificial intelligence and machine learning. The advisory committee will provide advice on scientific and technical issues including AI, digital therapeutics, wearables, and remote patient monitoring. The committee will consist of nine voting members and the chair, who possess technical and scientific expertise from a diverse array of backgrounds to improve FDA's understanding of the benefits, risks, and clinical outcomes associated with DHTs. The committee is expected to be fully operational in 2024.
A press release with more information is available here.
Impact on General Dentistry: AI and machine learning will likely have significant impacts on all of health care, including dentistry. Given that the consequences are still not understood, the AGD is encouraged by the commitment to studying digital health and is interested to learn how these DHTs could impact dentistry.
A press release with more information is available here.
Impact on General Dentistry: AI and machine learning will likely have significant impacts on all of health care, including dentistry. Given that the consequences are still not understood, the AGD is encouraged by the commitment to studying digital health and is interested to learn how these DHTs could impact dentistry.